Core Viewpoint - Hema Medical (03309.HK) announced a share buyback of 160,000 shares at a total cost of HKD 277,200, with a buyback price ranging from HKD 1.72 to HKD 1.74 per share [1] Company Summary - As of November 26, 2025, Hema Medical's stock closed at HKD 1.74, reflecting a 0.58% increase with a trading volume of 320,000 shares and a turnover of HKD 553,000 [1] - The market capitalization of Hema Medical is HKD 2.142 billion, ranking 15th in the medical services sector [1] Financial Metrics - Return on Equity (ROE): -6.36%, compared to the industry average of -0.02%, ranking 39th in the sector [1] - Market Capitalization: HKD 2.142 billion, while the industry average is HKD 7.938 billion, ranking 15th [1] - Revenue: HKD 1.935 billion, with the industry average at HKD 3.832 billion, ranking 15th [1] - Net Profit Margin: 5.95%, significantly better than the industry average of -843.36%, ranking 25th [1] - Gross Profit Margin: 31.12%, compared to the industry average of 39.76%, ranking 28th [1] - Debt Ratio: 29.8%, much lower than the industry average of 74.15%, ranking 21st [1]
希玛医疗(03309.HK)11月26日斥资27.72万港元回购16万股